1. A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins
   Krzysztof Pawłowski et al, 2010, BMC Genomics CrossRef
2. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
   Alexander Augustyn et al, 2014, Proceedings of the National Academy of Sciences CrossRef
3. Sex chromosomes drive gene expression and regulatory dimorphisms in mouse embryonic stem cells
   Rachael J. Werner et al, 2017, Biology of Sex Differences CrossRef
4. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy
   Wenqiang Zhang et al, 2024, Aging Cell CrossRef
5. Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs)
   Enrique Grande et al, 2010, Clinical and Translational Oncology CrossRef
6. Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid
   Yihebali Chi et al, 2016, Anti-Cancer Drugs CrossRef
7. Transcriptome signature of cellular senescence
   Gabriel Casella et al, 2019, Nucleic Acids Research CrossRef
8. The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase‐B
   Yukihiro Tambe et al, 2016, Molecular Carcinogenesis CrossRef
9. The molecular pathogenesis and management of bronchial carcinoids
   Mehtap Cakir et al, 2011, Expert Opinion on Therapeutic Targets CrossRef
10. Suppression of viral replication by drs tumor suppressor via mTOR dependent pathway
    Yukihiro Tambe et al, 2012, Cancer Letters CrossRef